AllQuantitative Report
logoArgusFebruary 24, 2021

NEO: Lowering target price to $55.00

Symbols
NEO
Sector(s)
Healthcare
Rating
Current Price
$38.11
Price Target
$NaN
Earnings Estimate
Summary

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free